Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of oral cladribine in relapsing-remitting multiple sclerosis
2004-005148-28Phase 3Completed
- Sponsor
- Merck Serono
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine in multiple sclerosis (MS), sponsored by Merck Serono. Started Apr 2005; status: completed.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-005148-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005148-28.